These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31315429)

  • 1. Deferral Versus Performance of Revascularization for Coronary Stenosis With Grey Zone Fractional Flow Reserve Values: A Systematic Review and Meta-Analysis.
    Du Y; Liu Y; Cai G; Yang B; Cheng Y; Liu J; Liu W; Liu X; Zhou Z; Zhao Y; Zhou Y
    Angiology; 2020 Jan; 71(1):48-55. PubMed ID: 31315429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.
    Escaned J; Ryan N; Mejía-Rentería H; Cook CM; Dehbi HM; Alegria-Barrero E; Alghamdi A; Al-Lamee R; Altman J; Ambrosia A; Baptista SB; Bertilsson M; Bhindi R; Birgander M; Bojara W; Brugaletta S; Buller C; Calais F; Silva PC; Carlsson J; Christiansen EH; Danielewicz M; Di Mario C; Doh JH; Erglis A; Erlinge D; Gerber RT; Going O; Gudmundsdottir I; Härle T; Hauer D; Hellig F; Indolfi C; Jakobsen L; Janssens L; Jensen J; Jeremias A; Kåregren A; Karlsson AC; Kharbanda RK; Khashaba A; Kikuta Y; Krackhardt F; Koo BK; Koul S; Laine M; Lehman SJ; Lindroos P; Malik IS; Maeng M; Matsuo H; Meuwissen M; Nam CW; Niccoli G; Nijjer SS; Olsson H; Olsson SE; Omerovic E; Panayi G; Petraco R; Piek JJ; Ribichini F; Samady H; Samuels B; Sandhall L; Sapontis J; Sen S; Seto AH; Sezer M; Sharp ASP; Shin ES; Singh J; Takashima H; Talwar S; Tanaka N; Tang K; Van Belle E; van Royen N; Varenhorst C; Vinhas H; Vrints CJ; Walters D; Yokoi H; Fröbert O; Patel MR; Serruys P; Davies JE; Götberg M
    JACC Cardiovasc Interv; 2018 Aug; 11(15):1437-1449. PubMed ID: 30093050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferred vs. performed revascularization for coronary stenosis with grey-zone fractional flow reserve values: data from the IRIS-FFR registry.
    Kang DY; Ahn JM; Lee CH; Lee PH; Park DW; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Eur Heart J; 2018 May; 39(18):1610-1619. PubMed ID: 29529177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revascularization Deferral of Nonculprit Stenoses on the Basis of Fractional Flow Reserve: 1-Year Outcomes of 8,579 Patients.
    Cerrato E; Mejía-Rentería H; Dehbi HM; Ahn JM; Cook C; Dupouy P; Baptista SB; Raposo L; Van Belle E; Götberg M; Davies JE; Park SJ; Escaned J
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1894-1903. PubMed ID: 32739305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Year Outcomes After Deferral of Revascularization Based on Fractional Flow Reserve: The J-CONFIRM Registry.
    Kuramitsu S; Matsuo H; Shinozaki T; Horie K; Takashima H; Terai H; Kikuta Y; Ishihara T; Saigusa T; Sakamoto T; Suematsu N; Shiono Y; Mizuno A; Tsujita K; Masamura K; Yokoi H; Tanaka N;
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008355. PubMed ID: 31884834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Treatment Strategy for Coronary Artery Stenoses with Grey Zone Fractional Flow Reserve Values. A Systematic Review and Meta-Analysis.
    Andreou C; Zimmermann FM; Tonino PAL; Maniotis C; Koutouzis M; Poulimenos LE; Triantafyllis AS
    Cardiovasc Revasc Med; 2020 Mar; 21(3):392-397. PubMed ID: 31227391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values.
    Megaly M; Khalil C; Saad M; Xenogiannis I; Omer M; Anantha Narayanan M; Pershad A; Garcia S; Seto AH; Burke MN; Brilakis ES
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008315. PubMed ID: 31752518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes According to Fractional Flow Reserve or Instantaneous Wave-Free Ratio in Deferred Lesions.
    Lee JM; Shin ES; Nam CW; Doh JH; Hwang D; Park J; Kim KJ; Zhang J; Ahn C; Koo BK
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2502-2510. PubMed ID: 29198458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve Assessment.
    Shiono Y; Kuramitsu S; Matsuo H; Horie K; Takashima H; Terai H; Kikuta Y; Ishihara T; Saigusa T; Sakamoto T; Suematsu N; Asano T; Tsujita K; Masamura K; Doijiri T; Toyota F; Ogita M; Kurita T; Matsuo A; Harada K; Yaginuma K; Sonoda S; Tanaka A; Yokoi H; Tanaka N;
    JACC Cardiovasc Interv; 2022 Feb; 15(4):427-439. PubMed ID: 35210049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies.
    Cerrato E; Echavarria-Pinto M; D'Ascenzo F; Gonzalo N; Quadri G; Quirós A; de la Torre Hernández JM; Tomassini F; Barbero U; Nombela-Franco L; Nuñez-Gil I; Biondi-Zoccai G; Macaya C; Varbella F; Escaned J
    Int J Cardiol; 2018 Nov; 271():42-48. PubMed ID: 30223378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements.
    Courtis J; Rodés-Cabau J; Larose E; Déry JP; Nguyen CM; Proulx G; Gleeton O; Roy L; Barbeau G; Noël B; DeLarochellière R; Bertrand OF
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):541-8. PubMed ID: 18307236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Lower Fractional Flow Reserve Values With Higher Risk of Adverse Cardiac Events for Lesions Deferred Revascularization Among Patients With Acute Coronary Syndrome.
    Masrani Mehta S; Depta JP; Novak E; Patel JS; Patel Y; Raymer D; Facey G; Zajarias A; Lasala JM; Singh J; Bach RG; Kurz HI
    J Am Heart Assoc; 2015 Aug; 4(8):e002172. PubMed ID: 26289346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Year Outcomes After Fractional Flow Reserve-Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry.
    Kuramitsu S; Matsuo H; Shinozaki T; Horie K; Takashima H; Terai H; Kikuta Y; Ishihara T; Saigusa T; Sakamoto T; Suematsu N; Shiono Y; Asano T; Tsujita K; Masamura K; Doijiri T; Toyota F; Ogita M; Kurita T; Matsuo A; Harada K; Yaginuma K; Sonoda S; Yokoi H; Tanaka N;
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011387. PubMed ID: 35130711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve).
    Ahn JM; Park DW; Shin ES; Koo BK; Nam CW; Doh JH; Kim JH; Chae IH; Yoon JH; Her SH; Seung KB; Chung WY; Yoo SY; Lee JB; Choi SW; Park K; Hong TJ; Lee SY; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ;
    Circulation; 2017 Jun; 135(23):2241-2251. PubMed ID: 28356440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Diabetic Patients.
    Alkhalil M; McCune C; McClenaghan L; Mailey J; Collins P; Kearney A; Todd M; McKavanagh P
    Cardiovasc Revasc Med; 2020 Jul; 21(7):897-902. PubMed ID: 31883978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of malondialdehyde-modified low-density lipoprotein on clinical outcomes after fractional flow reserve-guided deferral of revascularization.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Heart Vessels; 2021 May; 36(5):605-614. PubMed ID: 33219835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after deferral of revascularization in patients with intermediate coronary stenosis and gray-zone fractional flow reserve.
    Shiono Y; Kubo T; Tanaka A; Ino Y; Yamaguchi T; Tanimoto T; Yamano T; Matsuo Y; Nishiguchi T; Teraguchi I; Ota S; Ozaki Y; Orii M; Shimamura K; Kitabata H; Hirata K; Imanishi T; Akasaka T
    Circ J; 2015; 79(1):91-5. PubMed ID: 25410812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.
    Kennedy MW; Hermanides RS; Kaplan E; Hemradj V; Fabris E; Koopmans PC; Dambrink JE; Gosselink AT; Van't Hof AW; Ottervanger JP; Roolvink V; Remkes WS; van der Sluis A; Suryapranata H; Kedhi E
    Am J Cardiol; 2016 Nov; 118(9):1293-1299. PubMed ID: 27614852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.